alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
AEGIS SEF | 2829 Technology Forest Boulevard, Suite 260 | The Woodlands, Texas 77381

March 27, 2023

Submitted via Portal

Mr. Christopher J. Kirkpatrick

Office of the Secretariat

U.S. Commodity Futures Trading Commission

Three Lafayette Centre

1155 21st Street, N.W.

Washington, D.C. 20581

Re: Confidential Treatment Request – AEGIS Product Listing – Exhibit B

Dear Sir:

AEGIS SEF, LLC (“AEGIS SEF”) hereby requests that the U.S. Commodity Futures Trading

Commission (the “Commission”) accord confidential treatment to Exhibits B (“Exhibit”), which 

was submitted to the Commission as Self Certification on Product Listing(s) on this date. This 

request pertains to all material in the Exhibits. The Exhibits bear the designation “Confidential 

Treatment Requested by AEGIS SEF, LLC.”

This request for confidential treatment is made pursuant to Commission

Regulations 40.8, as Exhibit contains information that would reveal the

trade secrets or confidential commercial or financial information of AEGIS SEF and its

affiliates. 

Please contact the undersigned at 832-413-5973 or afurman@aegis-hedging.com with any 

questions regarding this matter.

Andrew Furman

Chief Compliance Officer

AEGIS SEF, LLC

2829 Technology Forest Blvd

Suite 260

The Woodlands, TX 77381
IN THE SUPREME COURT OF PENNSYLVANIA

MIDDLE DISTRICT

CITIBANK, N.A., AS TRUSTEE FOR THE WACHOVIA LOAN TRUST, 2005

- SD1

ASSET

- BACKED CERTIFICATES, SERIES

2005

- SD1 C/O WELLS FARGO BANK, N.A.

v.

LAWANDA A. JENNINGS A/K/A LAWANDA

A. JENNINGS

v.

FRANKLIN A. BENNETT III

PETITION OF: FRANKLIN A. BENNETT III :

:

:

:

:

:

:

:

:

:

:

:

:

:

:

:

:

:

:

: No. 259 MAL 2022

Petition for Allowance of Appeal from the Order of the Superior Court

CITIBANK, N.A., AS TRUSTEE FOR THE WACHOVIA LOAN TRUST, 2005

- SD1

ASSET

- BACKED CERTIFICATES, SERIES

2005

- SD1 C/O WELLS FARGO BANK, N.A.

v.

LAWANDA A. JENNINGS A/K/A LAWANDA

A. JENNINGS

v.

FRANKLIN A. BENNETT III

PETITION OF: FRANKLIN A. BENNETT III :

:

:

:

:

:

:

:

:

:

:

:

:

:

:

:

:

:

:

: No. 260 MAL 2022

Petition for Allowance of Appeal from the Order of the Superior Court[ 259 MAL 2022 and 260 MAL 2022 ]

- 2 ORDER

PER CURIAM

AND NOW , this 29th day of November, 2022

, the Petition for Allowance of Appeal

is DENIED

.
# In the United States Court of Federal Claims

OFFICE OF SPECIAL MASTERS

No. 1 9

- 217 V

UNPUBLISHED

JUDY H. BRINTLE

,

Petitioner,

v.

SECRETARY OF HEALTH AND

HUMAN SERVICES,

Respondent. Chief Special Master Corcoran

Filed: April 26, 2021

Special Processing Unit (SPU) ;

Rul ing on Entitlement; Concession;

Table Injury; Influenza (Flu) Vaccine;

Guillain

- Barre Syndrome (GBS)

Nancy Routh Meyers, Turning Point Litigation, Greensboro, NC , for petitioner.

Christine Mary Becer , U.S. Department of Justice, Washington, DC, for respondent.

RULING ON ENTITLEMENT 1

On February 7, 2019

, Judy H. Brintle filed a petition for compensation under the

National Vaccine Injury Compensation Program, 42 U.S.C. §300aa

- 10, et seq

. 2 (the

“Vaccine Act”). Petitioner alleges that she suffered Guillain

- Barre syndrome ( “ GBS ” ) as a

result of an influenza ( “ flu ” ) vaccin ation a dministered on September 24, 2017 . Petit ion at

1 . The case was assigned to the Special Processing Unit of the Office of Special Masters.

On April 23, 2021

, R espondent filed his Rule 4(c) report in which he concedes that

P etitioner is entitled to compensa tion in this case. Respondent’s Rule 4(c) Report at 1.

Specifically, R espondent has concluded that Petitioner h as satisfied the criteria set forth

in the Vaccine Inju ry Table and the Quali ficatio ns and Aids to Interpretation

. Id. at 8

- 9

.

1 Because this unpublished ruling contains a reasoned explanation for the action in this case, I am required

to post it on the United States Court of Federal Claims' website in accordance with the E

- Government Act

of 2002. 44 U.S.C. § 3501 note (2012) (Federal Management and Promotion of Electronic Government

Services). This means the ruling will be available to anyone with access to the internet. In accordance

with Vaccine Rule 18(b), Petitioner has 14 days to identify and move to redact medical or other information,

the disclosure of which would constitute an unwarranted invasion of privacy. If, upon review, I agree that

the identified material fits within this definition, I will redact such material from public access.

2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99

- 660, 100 Stat. 3755

. Hereinafter, for ease

of citation, all “§” references to the Vaccine Act will be to the pertinent subpara graph of 42 U.S.C. § 300aa

(2012 ).2 In view of R espondent’s position and the evidence of record, I find that

P etitioner is entitle d to compensation.

IT IS SO ORDERED.

s/ Brian H. Corcoran

Brian H. Corcoran

Chief Special Master
Case 1:07-cv-05346-AKH Document 13 Filed 01/28/2008 Page 1 of 5Case 1:07-cv-05346-AKH Document 13 Filed 01/28/2008 Page 2 of 5Case 1:07-cv-05346-AKH Document 13 Filed 01/28/2008 Page 3 of 5Case 1:07-cv-05346-AKH Document 13 Filed 01/28/2008 Page 4 of 5Case 1:07-cv-05346-AKH Document 13 Filed 01/28/2008 Page 5 of 5
November 16, 2023

Via E-mail

Assistant Secretary of the Commission for FOI, Privacy and Sunshine Acts Compliance

Commodity Futures Trading Commission

Three Lafayette Centre

1155 21st Street, NW

Washington, DC 20581

201-418-5000

FOIAsubmissions@cftc.gov

Re: FOIA Confidential Treatment Request 

Dear Sir or Madam:

ICE Clear Europe Limited (“Submitter”) hereby respectfully requests that the Commodity Futures Trading 

Commission (the “CFTC”) accord confidential treatment under 17 C.F.R. §145.9 in relation to the ‘Futures and 

Options Risk Policy’ document submitted today which bear the bates number 16.11.2023-000001-CFTC and 

16.11.2023-000041-CFTC and all information derived therefrom (collectively, the “Confidential Information”).

This request for confidential treatment is made pursuant to 17 C.F.R. §145.9(d) (1) because Submitter believes 

that the Confidential Information is covered by one or more exemptions in the Freedom of Information Act (the 

“FOIA”) (5 U.S.C. §552(b)) and is therefore exempt from the CFTC’s public disclosure requirements pursuant 

to 17 C.F.R. §145.5. In particular, 5 U.S.C. §552(b) (4) and 17 C.F.R. §145.9(d) (1) (ii) exempts disclosure that 

would reveal the Submitter’s trade secrets or confidential commercial or financial information. Submitter 

believes that the Confidential Information contains confidential commercial and financial information as well as 

proprietary information regarding business procedures and systems that should be protected from public 

disclosure pursuant to this exemption. Confidential treatment is requested for a period of five years. 

This request is not to be construed as a waiver of any other protection from disclosure or confidential treatment 

accorded by law, and Submitter will rely on and invoke any such confidentiality protection. Submitter requests 

that the CFTC advise the undersigned, pursuant to 17 C.F.R. §145.9(e) (1), in advance of any disclosure of the 

Confidential Information pursuant to the FOIA, so that this request for confidential treatment may be 

substantiated.

If you should have any questions or comments or require further information, please do not hesitate to contact the 

undersigned at philip.tooke@ice.com or +44 (0)20 3142 0842.

Very truly yours,

Philip Tooke

Senior Compliance Analyst
**EXHIBIT 32.2**

 

 

**CERTIFICATION OF**

**CHIEF FINANCIAL OFFICER**

**OF PIONEER SOUTHWEST ENERGY PARTNERS L.P.**

**PURSUANT TO 18 U.S.C. § 1350**

 

I, Richard P. Dealy, Executive Vice President and Chief Financial Officer of Pioneer Natural Resources GP LLC, the general partner of Pioneer Southwest Energy Partners L.P. (the "Partnership"), hereby certify that the accompanying Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2009 and filed with the Securities and Exchange Commission pursuant to Section            13(a) of the Securities Exchange Act of 1934 (the "Report") by the Partnership fully complies with the requirements of that section.

 

I further certify that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Partnership.

 

                

 

|   |   |                                  |   |
|--------|--------|---------------------------------------|--------|
|   |   | /s/ Richard P. Dealy                  |   |
|   | Name:  | Richard P. Dealy, Executive Vice      |   |
|   |   | President and Chief Financial Officer |   |
|   | Date:  | August 11, 2009                       |   |
#### Frank Miraglia, Respondent, v H & L Holding Corp., Defendant and Third-Party Plaintiff. Lane & Sons Construction Corp., Third-Party Defendant-Appellant.

Submitted December 28, 2009;

decided February 23, 2010

Motion, insofar as it seeks leave to appeal from that portion of the Appellate Division order that affirmed that part of Supreme Court’s order that denied third-party appellant Lane and Sons Construction Corp.’s motion to amend the judgment, dismissed upon the ground that such portion of the order does not finally determine the action within the meaning of the Constitution; motion for leave to appeal otherwise denied.
Exhibit 31.2
 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO
SECURITIES EXCHANGE ACT RULES 13a-14(a) AND 15d-14(a), AS ADOPTED PURSUANT
TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
      (a)
    
    Designed such disclosure controls and procedures, or caused
such disclosure controls and procedures to be designed
under our supervision, to ensure that material information
relating to the registrant, including its consolidated
subsidiaries, is made known to us by others within those
entities, particularly during the period in which this
report is being prepared;(b)
    
    Designed such internal control over financial reporting, or
caused such internal control over financial reporting to be
designed under our supervision, to provide reasonable
assurance regarding the reliability of financial reporting
and the preparation of financial statements for external
purposes in accordance with generally accepted accounting
principles;(c)
    
    Evaluated the effectiveness of the registrants disclosure
controls and procedures and presented in this report our
conclusions about the effectiveness of the disclosure
controls and procedures, as of the end of the period
covered by this report based on such evaluation; and(d)
    
    Disclosed in this report any change in the registrants
internal control over financial reporting that occurred
during the registrants most recent fiscal quarter (the
registrants fourth fiscal quarter in the case of an annual
report) that has materially affected, or is reasonably
likely to materially affect, the registrants internal
control over financial reporting; and
  (a)
    
    All significant deficiencies and material
weaknesses in the design or operation of
internal control over financial reporting
which are reasonably likely to adversely
affect the registrants ability to record,
process, summarize and report financial
information; and(b)
    
    Any fraud, whether or not material, that
involves management or other employees who
have a significant role in the registrants
internal control over financial reporting.
 Date: May 2, 2011
    /s/ Harpreet S. GrewalHarpreet S. GrewalExecutive Vice President and
Chief Financial Officer 38
#### Ettie R. LAWRENCE, Petitioner, v. OFFICE OF PERSONNEL MANAGEMENT, Respondent.

No. 05-3036.

United States Court of Appeals, Federal Circuit.

May 1, 2006.

*ORDER*

Upon consideration of the parties’ joint motion to dismiss this petition for review, *955from the decision of the Merit System Protection Board ease no. DA0831030414-1-1,

IT IS ORDERED THAT:

(1) The motion is granted.

(2) Each side shall bear its own costs.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Federal Reserve System

                    The companies listed in this notice have given notice under section 4 of the Bank Holding Company Act (12 U.S.C. 1843) (BHC Act) and Regulation Y (12 CFR Part 225) to engage                     *de novo*, or to acquire or control voting securities or assets of a company, including the companies listed below, that engages either directly or through a subsidiary or other company, in a nonbanking activity that is listed in § 225.28 of Regulation Y (12 CFR 225.28) or that the Board has determined by Order to be closely related to banking and permissible for bank holding companies.  Unless otherwise noted, these activities will be conducted throughout the United States.                

Each notice is available for inspection at the Federal Reserve Bank indicated.  The notice also will be available for inspection at the offices of the Board of Governors.  Interested persons may express their views in writing on the question whether the proposal complies with the standards of section 4 of the BHC Act.  Additional information on all bank holding companies may be obtained from the National Information Center website at www.ffiec.gov/​nic/​.

Unless otherwise noted, comments regarding the applications must be received at the Reserve Bank indicated or the offices of the Board of Governors not later than June 4, 2001.

**A.****Federal Reserve Bank of Atlanta**                     (Cynthia C. Goodwin, Vice President) 104 Marietta Street, N.W., Atlanta, Georgia 30303-2713:                

*1.  Hancock Holding Company,*                     Gulfport, Mississippi; to acquire Lamar Data Solutions, Inc., Purvis, Mississippi, and thereby to engage de novo in data processing and data transmission services for financial institutions, pursuant to section 225.28(b)(14)(i) of Regulation Y.                

Board of Governors of the Federal Reserve System, May 15, 2001.

Robert deV. Frierson

Associate Secretary of the Board.

[FR Doc. 01-12629 Filed 5-18-01; 8:45 am]

BILLING CODE 6210-01-S
#### Elizabeth GREWAL, Plaintiff-Appellee, v. Amit CHOUDHURY, Defendant-Appellant.

No. 08-17483.

United States Court of Appeals, Ninth Circuit.

Submitted April 5, 2010.*

Filed April 21, 2010.

Amit Choudhury, Chicago, IL, pro se.

E. Jeffrey Banchero, Robert M. Licht-man, Scott R. Raber, The Banchero Law *618Firm, San Francisco, CA, for Plaintiff-Appellee.

Before: RYMER, McKEOWN, and PAEZ, Circuit Judges.

*

 The panel unanimously concludes this case is suitable for decision without oral argument. *See*Fed. R.App. P. 34(a)(2).

MEMORANDUM **

Amit Choudhury appeals pro se from the district court’s judgment, following a four-day jury trial, in favor of Elizabeth Grewal in her diversity action alleging various claims connected with a promissory note. We have jurisdiction pursuant to 28 U.S.C. § 1291. We affirm.

The district court did not abuse its discretion by excluding belatedly produced documents from use at trial. *See Yeti by Molly, Ltd. v. Deckers Outdoor Corp.,*259 F.3d 1101, 1105-06 (9th Cir.2001) (reviewing for an abuse of discretion the district court’s decision to exclude evidence as a discovery sanction and explaining that Fed.R.Civ.P. 37 requires the exclusion of evidence unless the failure to disclose was substantially justified and harmless).

The admission of expert testimony was not plain error because it aided the jury in calculating damages. *See Scott v. Ross,*140 F.3d 1275, 1285 (9th Cir.1998) (reviewing for plain error the admission of expert testimony where party fails to renew objection at trial and explaining that Fed. R.Evid. 702 allows for “testimony that will aid the trier of fact in understanding the evidence or determining a fact in issue”).

Contrary to Choudhury’s contention, there is no evidence in the record before us to suggest the jury ignored the instructions to calculate damages according to a simple interest formula, to disregard a portion of Grewal’s testimony, or to consider Choudhury’s ability to pay any punitive damages award. *See Fineberg v. United States,*393 F.2d 417, 419-20 (9th Cir.1968) (“The jury is presumed to have understood and followed the court’s instructions.”).

We do not consider Choudhury’s undeveloped contentions regarding his post-trial motions. *See Leer v. Murphy,*844 F.2d 628, 634 (9th Cir.1988) (“Issues raised in a brief which are not supported by argument are deemed abandoned.”).

Grewal’s request for judicial notice is denied.

AFFIRMED.

**

 This disposition is not appropriate for publication and is not precedent except as provid*619ed by 9th Cir. R. 36-3.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute of General Medical Sciences Special Emphasis Panel                    

*Date:*                         June 24-26, 2001.                    

*Time:*                         7:30 p.m. to 11:30 a.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Hilton Newark Gateway, Raymond Boulevard, Newark, NJ 07102.                    

*Contact Person:*                         Michael A. Sesma, Scientific Review Administrator, Office of Scientific Review, National Institute of General Medical Sciences, Natcher Building, Room 1AS19H, 45 Center Drive, Bethesda, MD 20892, (301) 594-2048, sesmam@nigms.nih.gov.                    

(Catalogue of Federal Domestic Assistance Program Nos. 93.375, Minority Biomedical Research Support; 93.821, Cell Biology and Biophysics Research; 93.859, Pharmacology, Physiology, and Biological Chemistry Research; 93.862, Genetics and Developmental Biology Research; 93.88, Minority Access to Research Careers; 93.96, Special Minority Initiatives, National Institutes of Health, HHS)

Dated: May 23, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. 01-13541  Filed 5-29-01; 8:45 am]

BILLING CODE 4140-01-M
N O T FO R PUB L ICAT IO N UNITED STATES C OUR T OF APPEALS FOR THE NINTH C IR C UIT JOAO AVELINO M ENESES PEDR O, a .k.a . John Pe dro, Pe titione r, v. ER IC H. HOLDER , Jr., Attorne y Ge ne ra l, R

e sponde nt . No. 12-73559 Age n c y No. A036-066-382 M EM O R ANDUM *

On Pe tition for Re vie w of a n Orde r of the B oa rd of Im m igration Appe a ls Subm itte d July 22, 2014 ** B e fore : GOODW IN, C ANB Y, a nd C ALLAHAN, C irc uit Judge s . Joa o Ave l ino M e ne se s Pe dro, a native and c itiz e n of Portuga l, pe titions for re vie w of a

n orde r of the B oa

rd of Im m igrat ion Appe a ls (“ B IA” ) de ny ing his m otion to re o pe n re m ova l proc e e dings. W e dism iss thepe tition for re vie w. 

# F IL ED JUL 30 2014 M OLLY C. DW Y ER, CLERK U . S. CO URT O F APPEALS

* This disposition is not a ppropria te for public at ion a

nd is not pre c e de nt e xc e pt a s provide d

by 9th C ir. R . 36-3. ** The pa

ne l una nim ously c onc lude s this c a se is suita ble for de c ision without oral a

rgum e nt. Se e Fe d. R . App. P. 34(a)(2).M e ne se s Pe dro’ s undispute d re m ova bility for an a ggravate d-fe lony c onvic tion unde r 8 U.S.C . § 1227(a)(2)(A)(iii) lim i ts our jurisdic tion to c olora ble c onstitutiona

l c la im s a nd que stions of la

w. Se e8 U.S.C . § 1252(a)(2)(C )-(D); se e also G hahre mani v . Gonzale s , 498 F.3d 993, 998 n.5 (9th C ir. 2007) (“ [W ] ithdra

wa l of judic ia l re v i e w ove r fina l orde rs of de porta tion a l so withdra

ws jurisdic tion from

m otions . . . to re ope n de porta tion proc e e dings for those a lie ns de porta ble for having c om

m itte d a c rim e e num e rate d in thesta tute .” (c ita

tion om i tte d)). M e ne se s Pe dro ha s fa ile d to ra ise a c olora ble c onstitutiona

l c la im or que stion of la

w tha t would invoke

our jurisdic t ion unde r 8 U.S.C . § 1252(a)(2)(D). Se e M e nde z-C astro v . Muk

ase y , 552 F.3d 975, 978 (9th C ir. 2009) (“ To be c olora ble in this c onte xt, the [c onstitutiona l c la im or que stion of la

w] ne e d not be substa ntia l, but thec la im

m ust ha ve som e possibleva lidity .” (c ita t ion om itte d)). PE T IT IO N FO R RE V IE WDISM ISSE D.

1 2 - 7 3 5 5 9 2
Cheetah Oil & Gas Ltd.: Exhibit 10.3 - Filed by newsfilecorp.com






DEMAND PROMISSORY NOTE

	              	 September 13, 2010 
	USD $24,000 	 



	To: 	Cornelius O’Connell, 
	  	919 St. Charles Street, 
	  	Victoria, B.C. V8S 3P7 


FOR VALUE RECEIVED CHEETAH OIL & GAS Ltd. (the “Borrower”)
acknowledges itself indebted and promises to pay to, or to the order of, the
Lender at the address indicated, the sum of TWENTY FOUR THOUSAND DOLLARS USD
($24,000) (the “Principal Sum”), together with interest on the outstanding
Principal Sum from time to time at a rate equal to 15% PER ANNUM, both before
and after maturity, ON DEMAND, subject to any restrictions on such demand as set
out in a Loan Agreement between the Lender and the Borrower dated as of
September 13, 2010.

If any payment is not made when required to be made in
accordance with the promissory note, interest is to be paid by the Borrower on
such overdue amounts, including any accrued and unpaid interest in the same
manner as is paid on the Principal Sum.

The Borrower waives presentment for payment, protest or notice
of protest and notice of dishonour of this promissory note.

DATED at Nanaimo, British Columbia, this 13 day of September,
2010.

	 	CHEETAH OIL & GAS LTD. 
	 	 
	 	 
	 	Signature: 
	 	Donald Findlay, President 
	 	  
	 	  
	 	CHEETAH OIL & GAS LTD. 
	 	  
	 	
	 	Signature: 
	 	Robert McAllister, CEO